MedPath

Ayurveda as Prophylaxis for Suspected COVID-19 Patients

Not Applicable
Withdrawn
Conditions
Covid-19
Registration Number
NCT04395976
Lead Sponsor
British Ayurvedic Medical Council
Brief Summary

Despite worldwide efforts to contain, manage and treat Covid-19, the pandemic is continuing to spread. This calls for an urgent clinically-proven prophylaxis and therapeutic strategy. Recent developments on the use of traditional medicines in Covid-19 management has drawn enough attention to start several research studies. Based on the Indian Traditional Medicine, Ayurveda's community initiatives, preliminary studies, and our experiential knowledge on Covid-19 settings, we propose present study to prevent the development of COVID-19 symptoms in people who live or have come contact with an individual diagnosed with COVID-19.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Person who has come into contact with confirmed COVID-19,
  • Willing to take study drug as directed
Exclusion Criteria
  • Confirmed current COVID-19
  • Inability to take medications orally
  • Inability to provide written consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Clinical confirmation of Covid-19From date of enrolment to 14 days

Number of participants with symptomatic, lab-confirmed COVID-19

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

British Ayurvedic Medical Council

🇬🇧

London, United Kingdom

British Ayurvedic Medical Council
🇬🇧London, United Kingdom

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.